President Joe Biden took his Bovid-1 vaccine booster shot on camera at the White House on Monday, just days after the CDC advisory committee recommended a third dose for a specific group.
The third dose of Pfizer-Biotech vaccine has been approved by the FDA and CDC for people over the age of 65, for the underlying health condition of people over the age of 18, and for those who are at high risk of contracting the virus because of their occupation.
Before receiving the injection, Biden blamed those who had not yet been shot, which he said now accounts for about 23 percent of the population.
“That individual minority has caused terrible damage to the rest of us,” he said. “It’s an unpublished epidemic.”
The booster shot will be taken months after the initial series of two shots. Pharmacies are instructed to handle booster shots based on their self-proof that they deserve it.
Infectious disease specialist Dr Anthony Anthony Fawcett said: “There will be temptations, for example, not to wait for six months for those who have recently been vaccinated.” “There’s an immunological reason why waiting is important, because you know that if you let the immune system mature in a few months, you can get more injuries from shots on your antibody growth. ”
The plan for booster shots was announced in August by eight top government physicians who noticed clear evidence that the effectiveness of the Covid-1 vaccine had declined over time. The Biden administration planned to start giving booster shots to Americans starting September 20.
On Sept. 17, an FDA advisory committee voted 16–3 against granting a booster for most people, but recommended it for those over 65 and at high risk. The CDC committee made similar recommendations last week.
There were some errors in the approval process. Two of the FDA’s top vaccine officials, Dr. Marion Gruber, director of the FDA’s Vaccine Research and Review Office, and her deputy, Dr. Philip Krauss announced plans to leave the agency in October and November late last month.
The two co-authors said in a study published in the scientific journal The Lancet that booster shots may only be suitable for at-risk populations.
The article states, “Although the benefits of the early Covid-1 vaccine clearly outweigh the risks, there may be risks if boosters are introduced too soon or too frequently, especially with vaccines that may have immune-mediated side effects … if unnecessary. Increased significant adverse reactions may result in vaccine intake that exceeds the COVID-19 vaccine.Thus, should be widely encouraged if there is clear evidence that it is appropriate.
Earlier this month, Biden issued an executive order ordering all federal employees to be vaccinated and calling for a new OSAA rule for businesses fined with more than 100 employees until they vaccinate their employees or the weekly Covid-1. wants to take tests.
Biden is scheduled to travel to Chicago on Wednesday to publicize the plan, and more businesses have been asked to issue vaccine orders.
This News Originally From – The Epoch Times